AIZ

Assurant, Inc.

NYSE • USD • FINANCIAL SERVICES • INSURANCE - SPECIALTY

Current Price $229.12 5 Years: +45.37%

52-Week Range

$183.39 $246.31

Current price is 72.7% of 52-week range

Key Metrics

Market Cap $11.8B
P/E Ratio N/A
Current Ratio N/A
EPS
Dividend Yield N/A
ATR(14) $4.91
Beta 0.6
PEG Ratio N/A
ROE N/A
Operating Earnings Growth Rate N/A

AI Overview

Last updated 30 days ago

Assurant is a “protection-as-a-service” insurer/administrator built around embedded distribution with OEMs, retailers, lenders and dealers across connected devices, autos and housing. That partnership-driven model creates switching costs and recurring fee/premium streams, and recent dealership-focused expansions (Holman) plus commercial-dealer enablement (Arcadium) reinforce distribution density. An APAC circular-operations acquisition also fits the device lifecycle trend (trade-in/repair/refurbishment), which can deepen economics per customer.

Financially, results have been strong: full-year 2025 GAAP net income rose to about $873M and adjusted EBITDA to about $1.54B, with revenue around $12.8B. Valuation looks reasonable for that quality: AIZ’s market cap is roughly $10.8B and the stock has traded around a low-to-mid teens P/E (about 13x recently), while capital returns are meaningful. Management guided 2026 adjusted EBITDA/EPS roughly consistent with 2025 on an excluding-catastrophes basis (and mid- to high-single-digit growth after adjusting for prior-year reserve development), with year-end liquidity cited around $887M.

The 12-month thesis is that steady underlying earnings growth plus disciplined capital returns can compound shareholder value even without multiple expansion. Key catalysts are execution on the planned $250M–$350M 2026 share repurchase program and continued high-single-digit growth in Global Lifestyle; a raised $0.88 quarterly dividend supports total return. Key risks are catastrophe volatility (management assumes roughly $180–$185M annual CAT load), partner concentration/renewal pressure, and any margin compression from higher claims severity in auto/device programs.

Recommendation: HOLD. The business is high-quality with shareholder-friendly capital returns, but with the stock already priced at a market-like multiple for an insurer and earnings guided to be roughly flat to modestly up in 2026 (ex-CATs), upside looks more incremental than asymmetric over the next year.

Price & Profitability History

5 Years change: +45.37% (+$71.51)

Log in